Skip to main content

Advertisement

Table 1 Clinicopathological analysis of BTF3 expression in prostate cancer

From: BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1

Variables BTF3 expression Total P Value
Negative and weak Moderate and strong
Age (years)     0.279
  < 65 16 (53.3) 14 (46.7) 30  
  > =65 114 (63.7) 65 (36.3) 179  
Pre PSA (ng/ml)     0.727
  < 4 9 (56.3) 7 (43.7) 16  
 4–10 15 (68.2) 7 (31.8) 22  
  > =10 94 (65.3) 50 (34.7) 144  
Gleason Score     0.006
  < 7 31 (83.8) 6 (16.2) 37  
 7 75 (72.8) 28 (27.2) 103  
  > 7 96 (59.6) 65 (40.4) 161  
Stage     0.02
 T1-T2 98 (65.8) 51 (34.2) 149  
 T3-T4 22 (46.8) 25 (53.2) 47  
Metastasis     0.005
 Negative 94 (67.1) 46 (32.9) 140  
 Positive 24 (45.3) 29 (54.7) 53  
Ki67     0.062
  < 10% 128 (65.6) 67 (34.4) 195  
  > 10% 10 (45.5) 12 (54.5) 22  
Biochemical recurrence     0.251
 Negative 17 (65.4) 9 (34.6) 26  
 Positive 42 (52.5) 38 (47.5) 80  
Clinical recurrence     < 0.001
 Negative 84 (72.4) 32 (27.6) 116  
 Positive 33 (46.5) 38 (53.5) 71  
CD44     0.042
 Negative 32 (91.4) 3 (8.6) 35  
 Positive 18 (69.2) 8 (30.8) 26  
SOX2     0.037
 Negative 39 (79.6) 10 (20.4) 49  
 Positive 6 (50) 6 (50) 12